Sculptor Capital LP - ACELRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$336,000
-4.5%
159,6000.0%0.00%0.0%
Q3 2019$352,000
-56.4%
159,600
-50.0%
0.00%
+100.0%
Q2 2019$808,000
+45.3%
319,200
+100.0%
0.00%
-50.0%
Q1 2019$556,000
-51.2%
159,600
-67.7%
0.00%
-50.0%
Q4 2018$1,140,000493,6000.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders